The Breathing Life Awards, UK
The 13th annual Breathing Life Awards will be taking place on Wednesday 28th May at Hilton Metropole and televised on Sky Real Lives (Sky channel 253) on Sunday 1st June, 9.30pm. Hosted by Carol Smillie and Dr David Bull, the glitzy awards ceremony celebrates the outstanding achievement of inspiring people that have Cystic Fibrosis (CF), the UK's most common life-threatening inherited disease.
Lung Transplants In Cystic Fibrosis Patients With Life Threatening Bacteria Sparks Debate At ISHLT Meeting
During Wednesday's Satellite Symposium 3: The Challenges of Lung Transplantation in Cystic Fibrosis (CF) at the International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting & Scientific Sessions, clinicians and researchers discussed some of the unique challenges in achieving excellent lung transplant outcomes in patients with CF.
Alabama Newborn Screening To Add Test For Cystic Fibrosis
The Alabama Department of Public Health in partnership with the cystic fibrosis centers at the University of Alabama at Birmingham, Children's Hospital of Alabama and the University of South Alabama announces further significant expansion of Alabama's newborn screening program.
Alabama Begins Mandatory Screening Of Newborns For Cystic Fibrosis
Alabama has joined 39 other states and the District of Columbia in requiring that all newborns be screened for cystic fibrosis at birth. "We congratulate Alabama for initiating a newborn screening program for cystic fibrosis, " said Robert J. Beall, Ph.
Dry Airways Play A Key Role In Asthma And Smoker's Lung
Dry airways may not only play a central role in the development of the in-herited lung disease cystic fibrosis, but also in much more common acquired chronic lung diseases such as asthma and smoker's lung, the ciga-rette smoke-induced chronic obstructive pulmonary disease (COPD).
Three New States Join Efforts To Screen Newborns For Cystic Fibrosis
Illinois and Vermont have joined 37 other states and the District of Columbia in requiring that all newborns be screened for cystic fibrosis at birth. In addition, the Nevada Department of Health has decided to begin regular CF screening as well. Routine screening will be implemented when state lawmakers set an implementation date.
Scorpion Peptide May Be Key To Secretory Diseases
Researchers have discovered a peptide in scorpion venom that may hold the key to understanding and controlling cystic fibrosis and other secretory diseases.In the December 28 issue of the Journal of Biological Chemistry, an international team of researchers describes how this novel peptide, called GaTx1, can control the movement of ions and water out of cells by interacting with a crucial chloride channel.
Increased Cystic Fibrosis Severity And Deficiency In The Protein MBL2 Linked
Cystic fibrosis (CF), a hereditary disorder causing thick mucous production and frequent lung infections, is associated with a high mortality rate primarily due to lung failure. Although it is known that mutations in the CFTR gene cause the disease, variations in other genes between individuals with CF modify the severity of the disease.
Decline In Cystic Fibrosis Since Introduction Of Prenatal Carrier Screening
A brief report in the February 28, 2008, New England Journal of Medicine, led by researchers at the New England Newborn Screening Program (NENSP) of the University of Massachusetts Medical School (UMMS), indicates a declining incidence of a genetic disease, providing what may be the first demonstration of a link between two independent population-based screening programs.
Computer Simulations Point To Key Molecular Basis Of Cystic Fibrosis
Researchers from the University of North Carolina at Chapel Hill have identified a key molecular mechanism that may account for the development of cystic fibrosis, which about 1 in 3000 children are born with in the US every year. The findings, published February 29 in the open-access journal PLoS Computational Biology, add new knowledge to understanding the development of this disease and may also point the way to new corrective treatments.